Latest Trials
| EudraCT Number: 2004-001557-29 | Sponsor Protocol Number: A2171035 | Start Date: 2006-11-24 | |||||||||||
| Sponsor Name: Pfizer Inc. | |||||||||||||
| Full Title: A 52-WEEK MULTICENTER, OPEN-LABEL, RANDOMIZED, PARALLEL, TWO - ARM STUDY COMPARING EXUBERA® (INHALED HUMAN INSULIN) VS. HUMALOG® (INSULIN LISPRO), BOTH IN COMBINATION WITH INSULIN GLARGINE IN SUBJE... | |||||||||||||
| Medical condition: Type 1 Diabetes | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Prematurely Ended) DE (Prematurely Ended) GB (Prematurely Ended) NL (Completed) IE (Prematurely Ended) AT (Prematurely Ended) FI (Prematurely Ended) FR (Completed) SE (Prematurely Ended) BE (Completed) PT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||